On Wegovy (semaglutide 2.4 mg, approved for chronic weight management): The FDA-approved prescribing information for Wegovy discloses that in the SELECT cardiovascular outcomes trial - a large study conducted in adults with established cardiovascular disease - hip and pelvis fractures were reported more often in female patients on Wegovy than in those on placebo: 1% (24/2,448) versus 0.2% (5/2,424)
Kaiser negotiates its own formulary, sets its own prior authorization criteria, and operates its own pharmacies
Among the metabolic alterations seen in cancers, the accumulation of specific metabolites, referred to as 'oncometabolites', has emerged as a significant contributor to tumor progression [18]
Relatively few studies have been conducted to elucidate the mechanisms of blast TBI and even fewer have examined the consequences of exposure to repetitive blast episodes
Morozov and published in Neuroendocrinology Letters enrolled 94 women between the ages of 66 and 94, all of whom lived at the War Veterans Home in St
In a typical healthy weight loss scenario, about 75 percent of weight loss comes from fat, while roughly 25 percent comes from fat-free mass, including muscle, says Sriram Machineni, MD, an endocrinology, diabetes, and metabolism expert at Montefiore Health Systems in New York City